Vanguard reorganizes reporting; affiliates to report DOCS holdings (DOCS)
Rhea-AI Filing Summary
The Vanguard Group amended its Schedule 13G to report zero shares beneficially owned of Doximity Inc. The filing states that on January 12, 2026 The Vanguard Group, Inc. underwent an internal realignment and certain subsidiaries will report beneficial ownership separately in reliance on SEC Release No. 34-39538.
The amendment lists 0 shares beneficially owned and 0% of the class, and explains that Vanguard no longer is deemed to beneficially own shares held by those reorganized subsidiaries.
Positive
- None.
Negative
- None.
Insights
Vanguard reports no beneficial ownership after internal realignment.
The amended Schedule 13G/A shows 0 shares and 0% ownership, stating that Vanguard realigned on January 12, 2026 and subsidiaries will report separately under SEC Release No. 34-39538. This is a reclassification of reporting responsibility, not a disclosed sale.
Practical implications depend on the subsidiary filings that follow; subsequent 13G/A or 13D entries by the individual subsidiaries will show where holdings are now reported.
Administrative disclosure reflecting disaggregation of beneficial ownership.
The filing attributes the change to an internal reorganization and cites SEC Release No. 34-39538 as the legal basis for separate reporting by subsidiaries. The statement clarifies that those subsidiaries pursue the same investment strategies previously used by Vanguard.
Observe subsequent filings from Vanguard affiliates for details on which entities hold shares and any reported percentages; timing and cash‑flow treatment are not included here.
FAQ
What change did The Vanguard Group report for DOCS ownership?
Does the amendment indicate Vanguard sold DOCS shares?
Will Vanguard affiliates still manage the same investments after realignment?
Where will DOCS holdings be reported after this amendment?
Who signed the Schedule 13G/A amendment for Vanguard?